The modeling approaches to investigate dose-response relationships for cancer and noncancer end points, and Other aspects of the protocol and associated documents. The EPA (2019a) document is ...
Diagnosis determines what illness is present; formulation explains why it takes its particular form in a given person. Both ...
NRC (2013) recommended that EPA address whether high dose exposures influence the shape of the dose-response curve. This could be addressed by performing sensitivity analyses in which the high level ...